WBI Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
WBI Investments's GILD Position: Q1 2026 in Review
WBI Investments sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 5,181 shares — an estimated $636K sold.
WBI Investments first reported a position in GILD in Q4 2014 and held it in 20 quarters. The position peaked at $12.8M in Q2 2019. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- WBI Investments reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
- WBI Investments sold 5,181 Gilead Sciences shares in Q1 2026, an estimated $636K.
- WBI Investments first reported a position in Gilead Sciences in Q4 2014 and held it in 20 quarters.
- WBI Investments's Gilead Sciences position peaked at $12.8M in Q2 2019.
- 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on WBI Investments's 13F filing for Q1 2026, filed 11 May 2026.